India’s Covaxin led to tolerable safety outcomes and enhanced immune responses: Lancet, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

According to the Lancet, all adverse events were mild and moderate and were more frequent after the first dose., According to the Lancet, all adverse events were mild and moderate and were more frequent after the first dose., , Read More

Leave a Reply

Your email address will not be published.